Continue reading<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Today, the U.S. Food and Drug Administration approved Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy indicated for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients 2 months of age and older. Continue reading<\/p>\n","protected":false},"author":1,"featured_media":5736,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[19],"tags":[],"class_list":["post-4267","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"\n
FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease<\/title>\n<meta name=\"description\" content=\"Today, the U.S. Food and Drug Administration approved Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy indicated for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients 2 months of age and older. Continue reading\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/Today,%20the%20U.S.%20Food%20and%20Drug%20Administration%20approved%20Ryoncil%20(remestemcel-L-rknd),%20an%20allogeneic%20(donor)%20bone%20marrow-derived%20mesenchymal%20stromal%20cell%20(MSC)%20therapy%20indicated%20for%20the%20treatment%20of%20steroid-refractory%20acute%20graft-versus-host%20disease%20(SR-aGVHD)%20in%20pediatric%20patients%202%20months%20of%20age%20and%20older.%20Continue%20reading\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease\" \/>\n<meta property=\"og:description\" content=\"Today, the U.S. Food and Drug Administration approved Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy indicated for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients 2 months of age and older. Continue reading\" \/>\n<meta property=\"og:url\" content=\"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Biogroup Vietnam\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-07T04:28:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-29T07:00:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/e8gzK3OGL4VtcHJz7GAdvpVFFkwVZcbK6OiHYSiA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1088\" \/>\n\t<meta property=\"og:image:height\" content=\"599\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/78a1c640012e6e7bc2bdf0d0fbffea95\"},\"headline\":\"FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease\",\"datePublished\":\"2025-01-07T04:28:47+00:00\",\"dateModified\":\"2025-09-29T07:00:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/\"},\"wordCount\":862,\"image\":{\"@id\":\"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/e8gzK3OGL4VtcHJz7GAdvpVFFkwVZcbK6OiHYSiA.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/\",\"url\":\"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/\",\"name\":\"FDA Ch\u1ea5p Thu\u1eadn Li\u1ec7u Ph\u00e1p T\u1ebf B\u00e0o G\u1ed1c Trung M\u00f4 \u0110\u1ea7u Ti\u00ean \u0110\u1ec3 \u0110i\u1ec1u Tr\u1ecb B\u1ec7nh Gh\u00e9p Ch\u1ed1ng V\u1eadt Ch\u1ee7 C\u1ea5p T\u00ednh Kh\u00e1ng Steroid\",\"isPartOf\":{\"@id\":\"https:\/\/biogroupvietnam.com\/vi\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/e8gzK3OGL4VtcHJz7GAdvpVFFkwVZcbK6OiHYSiA.jpg\",\"datePublished\":\"2025-01-07T04:28:47+00:00\",\"dateModified\":\"2025-09-29T07:00:13+00:00\",\"author\":{\"@id\":\"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/78a1c640012e6e7bc2bdf0d0fbffea95\"},\"description\":\"B\u1ec7nh gh\u00e9p ch\u1ed1ng v\u1eadt ch\u1ee7 c\u1ea5p t\u00ednh kh\u00e1ng steroid l\u00e0 t\u00ecnh tr\u1ea1ng nghi\u00eam tr\u1ecdng v\u00e0 \u0111e d\u1ecda t\u00ednh m\u1ea1ng c\u00f3 th\u1ec3 x\u1ea3y ra nh\u01b0 m\u1ed9t bi\u1ebfn ch\u1ee9ng c\u1ee7a gh\u00e9p t\u1ebf b\u00e0o g\u1ed1c t\u1ea1o m\u00e1u (m\u00e1u) \u0111\u1ed3ng lo\u1ea1i (allo-HSCT).\",\"breadcrumb\":{\"@id\":\"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/#primaryimage\",\"url\":\"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/e8gzK3OGL4VtcHJz7GAdvpVFFkwVZcbK6OiHYSiA.jpg\",\"contentUrl\":\"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/e8gzK3OGL4VtcHJz7GAdvpVFFkwVZcbK6OiHYSiA.jpg\",\"width\":1088,\"height\":599,\"caption\":\"FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Biogroup Vietnam | End-to-End Biotechnology Solutions\",\"item\":\"https:\/\/biogroupvietnam.com\/vi\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\/\/biogroupvietnam.com\/vi\/su-kien-va-tin-tuc\/tin-tuc\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/biogroupvietnam.com\/en\/vi\/#website\",\"url\":\"https:\/\/biogroupvietnam.com\/en\/vi\/\",\"name\":\"Biogroup Vietnam\",\"description\":\"Biogroup Vietnam cung c\u1ea5p d\u1ecbch v\u1ee5 k\u1ef9 thu\u1eadt c\u00f9ng thi\u1ebft b\u1ecb, v\u1eadt t\u01b0, h\u00f3a ch\u1ea5t v\u00e0 gi\u1ea3i ph\u00e1p sinh h\u1ecdc cho ph\u00f2ng th\u00ed nghi\u1ec7m c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, y sinh v\u00e0 y h\u1ecdc t\u00e1i t\u1ea1o.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/biogroupvietnam.com\/en\/vi\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/78a1c640012e6e7bc2bdf0d0fbffea95\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/biogroupvietnam.com\/wp-content\/litespeed\/avatar\/eb8a826cba57879e3cdbbc4f5ece34eb.jpg?ver=1776157819\",\"contentUrl\":\"https:\/\/biogroupvietnam.com\/wp-content\/litespeed\/avatar\/eb8a826cba57879e3cdbbc4f5ece34eb.jpg?ver=1776157819\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/freshfromnature.vn\/\"],\"url\":\"https:\/\/biogroupvietnam.com\/en\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease","description":"Today, the U.S. Food and Drug Administration approved Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy indicated for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients 2 months of age and older. Continue reading","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"Today, the U.S. Food and Drug Administration approved Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy indicated for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients 2 months of age and older. Continue reading","og_locale":"en_US","og_type":"article","og_title":"FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease","og_description":"Today, the U.S. Food and Drug Administration approved Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy indicated for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients 2 months of age and older. Continue reading","og_url":"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/","og_site_name":"Biogroup Vietnam","article_published_time":"2025-01-07T04:28:47+00:00","article_modified_time":"2025-09-29T07:00:13+00:00","og_image":[{"width":1088,"height":599,"url":"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/e8gzK3OGL4VtcHJz7GAdvpVFFkwVZcbK6OiHYSiA.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/#article","isPartOf":{"@id":"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/"},"author":{"name":"admin","@id":"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/78a1c640012e6e7bc2bdf0d0fbffea95"},"headline":"FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease","datePublished":"2025-01-07T04:28:47+00:00","dateModified":"2025-09-29T07:00:13+00:00","mainEntityOfPage":{"@id":"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/"},"wordCount":862,"image":{"@id":"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/e8gzK3OGL4VtcHJz7GAdvpVFFkwVZcbK6OiHYSiA.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/","url":"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/","name":"FDA Ch\u1ea5p Thu\u1eadn Li\u1ec7u Ph\u00e1p T\u1ebf B\u00e0o G\u1ed1c Trung M\u00f4 \u0110\u1ea7u Ti\u00ean \u0110\u1ec3 \u0110i\u1ec1u Tr\u1ecb B\u1ec7nh Gh\u00e9p Ch\u1ed1ng V\u1eadt Ch\u1ee7 C\u1ea5p T\u00ednh Kh\u00e1ng Steroid","isPartOf":{"@id":"https:\/\/biogroupvietnam.com\/vi\/#website"},"primaryImageOfPage":{"@id":"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/#primaryimage"},"image":{"@id":"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/e8gzK3OGL4VtcHJz7GAdvpVFFkwVZcbK6OiHYSiA.jpg","datePublished":"2025-01-07T04:28:47+00:00","dateModified":"2025-09-29T07:00:13+00:00","author":{"@id":"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/78a1c640012e6e7bc2bdf0d0fbffea95"},"description":"B\u1ec7nh gh\u00e9p ch\u1ed1ng v\u1eadt ch\u1ee7 c\u1ea5p t\u00ednh kh\u00e1ng steroid l\u00e0 t\u00ecnh tr\u1ea1ng nghi\u00eam tr\u1ecdng v\u00e0 \u0111e d\u1ecda t\u00ednh m\u1ea1ng c\u00f3 th\u1ec3 x\u1ea3y ra nh\u01b0 m\u1ed9t bi\u1ebfn ch\u1ee9ng c\u1ee7a gh\u00e9p t\u1ebf b\u00e0o g\u1ed1c t\u1ea1o m\u00e1u (m\u00e1u) \u0111\u1ed3ng lo\u1ea1i (allo-HSCT).","breadcrumb":{"@id":"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/#primaryimage","url":"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/e8gzK3OGL4VtcHJz7GAdvpVFFkwVZcbK6OiHYSiA.jpg","contentUrl":"https:\/\/biogroupvietnam.com\/wp-content\/uploads\/2025\/08\/e8gzK3OGL4VtcHJz7GAdvpVFFkwVZcbK6OiHYSiA.jpg","width":1088,"height":599,"caption":"FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease"},{"@type":"BreadcrumbList","@id":"https:\/\/biogroupvietnam.com\/en\/news\/fda-approves-first-mesenchymal-stromal-cell-therapy-to-treat-steroid-refractory-acute-graft-versus-host-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Biogroup Vietnam | End-to-End Biotechnology Solutions","item":"https:\/\/biogroupvietnam.com\/vi\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/biogroupvietnam.com\/vi\/su-kien-va-tin-tuc\/tin-tuc\/"},{"@type":"ListItem","position":3,"name":"FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease"}]},{"@type":"WebSite","@id":"https:\/\/biogroupvietnam.com\/en\/vi\/#website","url":"https:\/\/biogroupvietnam.com\/en\/vi\/","name":"Biogroup Vietnam","description":"Biogroup Vietnam cung c\u1ea5p d\u1ecbch v\u1ee5 k\u1ef9 thu\u1eadt c\u00f9ng thi\u1ebft b\u1ecb, v\u1eadt t\u01b0, h\u00f3a ch\u1ea5t v\u00e0 gi\u1ea3i ph\u00e1p sinh h\u1ecdc cho ph\u00f2ng th\u00ed nghi\u1ec7m c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, y sinh v\u00e0 y h\u1ecdc t\u00e1i t\u1ea1o.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/biogroupvietnam.com\/en\/vi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/78a1c640012e6e7bc2bdf0d0fbffea95","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/biogroupvietnam.com\/vi\/#\/schema\/person\/image\/","url":"https:\/\/biogroupvietnam.com\/wp-content\/litespeed\/avatar\/eb8a826cba57879e3cdbbc4f5ece34eb.jpg?ver=1776157819","contentUrl":"https:\/\/biogroupvietnam.com\/wp-content\/litespeed\/avatar\/eb8a826cba57879e3cdbbc4f5ece34eb.jpg?ver=1776157819","caption":"admin"},"sameAs":["https:\/\/freshfromnature.vn\/"],"url":"https:\/\/biogroupvietnam.com\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/posts\/4267","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/comments?post=4267"}],"version-history":[{"count":3,"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/posts\/4267\/revisions"}],"predecessor-version":[{"id":8051,"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/posts\/4267\/revisions\/8051"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/media\/5736"}],"wp:attachment":[{"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/media?parent=4267"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/categories?post=4267"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biogroupvietnam.com\/en\/wp-json\/wp\/v2\/tags?post=4267"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}